about
Momordica charantia leaf extract suppresses rat prostate cancer progression in vitro and in vivoLack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) rat hepatocarcinogenesis by caffeine, a CYP1A2 inducer, points to complex counteracting influencesIntravascular lymphomatosis mimicking primary central nervous system lymphoma: a case report and literature reviewSpecific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissue.Establishment of a syngeneic orthotopic model of prostate cancer in immunocompetent rats.Chemopreventive effect of resveratrol and apocynin on pancreatic carcinogenesis via modulation of nuclear phosphorylated GSK3β and ERK1/2Connexin 32 dysfunction promotes ethanol-related hepatocarcinogenesis via activation of Dusp1-Erk axisPreventive Effects of Fermented Brown Rice and Rice Bran against Prostate Carcinogenesis in TRAP RatsImmunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by leuprorelin, a luteinizing hormone-releasing hormone agonist.High mobility group box associated with cell proliferation appears to play an important role in hepatocellular carcinogenesis in rats and humans.Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis.The NADPH Oxidase Inhibitor Apocynin Suppresses Preneoplastic Liver Foci of Rats.Histone Deacetylase Inhibition in Prostate Cancer Triggers miR-320-Mediated Suppression of the Androgen Receptor.Connexin 32 and luteolin play protective roles in non-alcoholic steatohepatitis development and its related hepatocarcinogenesis in rats.A novel photodynamic therapy targeting cancer cells and tumor-associated macrophages.Establishment of an invasive prostate cancer model in transgenic rats by intermittent testosterone administration.GPX2 overexpression is involved in cell proliferation and prognosis of castration-resistant prostate cancer.Apocynin, an NADPH oxidase inhibitor, suppresses rat prostate carcinogenesis.Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis.Apocynin, an NADPH oxidase inhibitor, suppresses progression of prostate cancer via Rac1 dephosphorylation.Purple corn color inhibition of prostate carcinogenesis by targeting cell growth pathways.Effects of co-administration of dietary sodium arsenate and 2,3-dimercaptopropane-1-sulfonic acid (DMPS) on the rat bladder epithelium.Kuguacin J, a triterpeniod from Momordica charantia leaf, modulates the progression of androgen-independent human prostate cancer cell line, PC3.Evaluation of direct and indirect effects of the PPARγ agonist troglitazone on mouse endothelial cell proliferation.Reactive angioendotheliomatosis of the intestine.Effects of an epidermal growth factor receptor inhibitor on arsenic associated toxicity in the rat bladder epithelium.IV injection of polystyrene beads for mouse model of sepsis causes severe glomerular injury.Cytotoxicity of combinations of arsenicals on rat urinary bladder urothelial cells in vitro.Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats.Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells.Expression and subcellular localization of AT motif binding factor 1 in colon tumours.Effect of sodium arsenite dose administered in the drinking water on the urinary bladder epithelium of female arsenic (+3 oxidation state) methyltransferase knockout mice.Severe systemic toxicity and urinary bladder cytotoxicity and regenerative hyperplasia induced by arsenite in arsenic (+3 oxidation state) methyltransferase knockout mice. A preliminary report.Suppressive effects of dietary genistin and daidzin on rat prostate carcinogenesis.Time course of urothelial changes in rats and mice orally administered arsenite.Lack of modification of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)-induced hepatocarcinogenesis in rats by fenbendazole--a CYP1A2 inducer.Organ differences in the enhancing potential of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine on carcinogenicity in the prostate, colon and pancreas.Down-regulated expression of prostasin in high-grade or hormone-refractory human prostate cancers.Age-dependent histopathological findings in the prostate of probasin/SV40 T antigen transgenic rats: lack of influence of carcinogen or testosterone treatment.
P50
Q28571031-2019D6F0-7177-4A5F-BB25-F62DD09768C8Q28580296-5C07841D-4D4D-4F5F-B50C-8E4EB6BB2B15Q30807892-23AED43D-9227-42FE-93F3-AB77C5B46C5EQ31031015-6A5F945B-E695-49FF-8D63-C27D004BAE91Q35110884-F4830ABD-3E40-4359-9BDF-21EB62A69CE3Q36619084-76C1FBAD-ADFE-49CD-9EA0-D4206DBEC51EQ36739026-5F1A9F39-D572-4B9A-A03B-A3390C38CA8DQ37133065-E4D61F8A-55DD-4BA6-AA0E-698C6DB5AB51Q37565103-D4EF4777-31CE-4F69-A7A7-7384A59D4783Q38312784-CCBE6616-2857-4470-9D7E-231E577318CBQ38511610-F8140FF7-2D29-4734-A40A-2DBFD890008BQ38726257-4E0F31FB-B281-4402-A532-CC30309E2EBAQ38749217-76241A3D-176F-485B-BA41-4F3B17AA4B23Q38769067-BCDB4555-DD1E-40B7-983B-49BBFB402732Q38825737-8A2655C0-5E8E-487D-9D2D-FCA4A5BF671CQ38928196-025A748E-E3F9-43C8-85E1-FD9341FCAE60Q38972606-9C1E5460-68B5-4E55-9EFE-0ED6F4AEEBA3Q39021568-E111C0D9-D00B-4819-B31A-052763345351Q39080681-4E28F6CB-4E2C-43D4-A037-C9D95F414E22Q39115848-66174F66-B6F4-47E6-9A47-1D3E0611567BQ39153631-AA9CEF4E-5EAB-43EE-A4C6-5C5F6DCED883Q39235273-6F4721CE-EDDD-4C4F-82D3-ED506231AD44Q39337362-A3D2BCFD-2B2A-476F-914A-EE9D6B14ACC0Q39408335-CD89D749-37A4-49DF-B2FB-00AE7721EEA4Q39470072-B0C33080-0308-463B-9387-7C8BB4D744A8Q39679720-F70949B6-C8BC-40D1-8E13-969368BDCA13Q39853788-E7C07E98-6CB1-45B6-9A4F-07EB373832FFQ39894060-05304E17-0C34-4EB2-94D0-940C9D47022FQ39978891-F51D1230-F7B2-4286-AAAF-FA88435DAE6CQ42483616-306B89C9-29C7-46F1-93C9-4BB28738F548Q42507939-80EDB072-32CF-437F-821F-953B26863D02Q42546682-07744213-5990-43FE-85E9-BB5CBDD822ACQ42746895-132DAB10-89A8-4BBF-ADC6-D72299533CE2Q43083935-27F3D84B-EDA2-42BD-884D-25799AFA7828Q43506589-D60D9B42-4498-4BCA-A1C1-7F3194139AF3Q43507594-31BDF874-797E-4F18-A0FC-C9A2074FCD2CQ44079547-10E9E8D6-B282-4E4B-914E-B2C20C9FB2ACQ44154918-98E3DA2F-0D86-4CCC-91D6-70118882C452Q44272373-0813B7B5-0FFF-40EE-B5CF-10D8CC35C9AEQ44412181-4AE0A992-458C-4B5E-A54B-63428FAE81D6
P50
description
Forscher
@de
investigador
@es
researcher
@en
ricercatore
@it
wetenschapper
@nl
研究員
@ja
研究者
@zh
name
Shugo Suzuki
@en
Shugo Suzuki
@nl
type
label
Shugo Suzuki
@en
Shugo Suzuki
@nl
prefLabel
Shugo Suzuki
@en
Shugo Suzuki
@nl
P106
P31
P496
0000-0001-8938-9670